|
[1]
|
Shin, D.H., Smith, D.M. and Choi, J.Y. (2022) SARS‐CoV‐2 Omicron Variant of Concern: Everything You Wanted to Know about Omicron but Were Afraid to Ask. Yonsei Medical Journal, 63, 977-983. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Chu, H. and Yuen, K. (2022) Pathogenicity of SARS‐CoV‐2 Omicron. Clinical and Translational Medicine, 12, e880. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Mullard, J.C.R., Kawalek, J., Parkin, A., Rayner, C., Mir, G., Sivan, M., et al. (2023) Towards Evidence-Based and Inclusive Models of Peer Support for Long Covid: A Hermeneutic Systematic Review. Social Science & Medicine, 320, Article 115669. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Zhong, H., Zhou, Y., Mei, S., Tang, R., Feng, J., He, Z., et al. (2022) Scars of COVID-19: A Bibliometric Analysis of Post-COVID-19 Fibrosis. Frontiers in Public Health, 10, Article 967829. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
George, P.M., Wells, A.U. and Jenkins, R.G. (2020) Pulmonary Fibrosis and COVID-19: The Potential Role for Antifibrotic Therapy. The Lancet Respiratory Medicine, 8, 807-815. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lazar, M., Barbu, E.C., Chitu, C.E., Tiliscan, C., Stratan, L., Arama, S.S., et al. (2022) Interstitial Lung Fibrosis Following COVID-19 Pneumonia. Diagnostics, 12, Article 2028. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Mohammadi, A., Balan, I., Yadav, S., Matos, W.F., Kharawala, A., Gaddam, M., et al. (2022) Post-COVID-19 Pulmonary Fibrosis. Cureus, 14, e22770. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Mo, X., Jian, W., Su, Z., Chen, M., Peng, H., Peng, P., et al. (2020) Abnormal Pulmonary Function in COVID-19 Patients at Time of Hospital Discharge. European Respiratory Journal, 55, Article 2001217. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Karyakarte, R.P., Das, R., Rajmane, M.V., Dudhate, S., Agarasen, J., Pillai, P., et al. (2023) The Burden and Characteristics of Post-COVID-19 Conditions among Laboratory-Confirmed Delta and Omicron COVID-19 Cases: A Preliminary Study from Maharashtra, India. Cureus, 15, e44888. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Donoso-Navarro, E., Arribas Gómez, I. and Bernabeu-Andreu, F.A. (2021) IL-6 and Other Biomarkers Associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid. Biomarker Insights, 16. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Al-Shami, I., Hourani, H.M.A. and Alkhatib, B. (2023) The Use of Prognostic Nutritional Index (PNI) and Selected Inflammatory Indicators for Predicting Malnutrition in COVID-19 Patients: A Retrospective Study. Journal of Infection and Public Health, 16, 280-285. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Yarmohammadi, A., Yarmohammadi, M., Fakhri, S. and Khan, H. (2021) Targeting Pivotal Inflammatory Pathways in COVID-19: A Mechanistic Review. European Journal of Pharmacology, 890, Article 173620. [Google Scholar] [CrossRef] [PubMed]
|